Your session is about to expire
← Back to Search
Overfeeding Effects on Obesity (EAT 2 Trial)
EAT 2 Trial Summary
This trial looks at how fat tissue changes when people gain weight, and how this affects their health.
EAT 2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowEAT 2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 4 trial • 200 Patients • NCT01342510EAT 2 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I regularly use weight loss medications that could affect the study.You have been diagnosed with a mental condition that causes you to lose touch with reality.I am not on long-term medications that significantly affect my weight.I have had surgery for weight loss.Your weight has been changing a lot in the past 3 months, by about 7 pounds up or down.You have tested positive for HIV, hepatitis B, or hepatitis C.I do not have major organ disease or significant liver problems.I have had a partial or full hysterectomy.I agree to use effective birth control or practice abstinence during the study.I am a man or a pre-menopausal woman aged 18-42.You have a history of eating disorders.I have had cancer within the last 5 years, but skin cancer might be an exception.I am willing to be assigned to one of two treatment groups by chance.You have smoked or used tobacco products in the past 3 months.Polycystic ovary syndrome (PCOS)I have been using anti-depressants for less than 3 months.Your body mass index (BMI) is between 25 and 30 kg/m2.I have diabetes or my fasting blood sugar is over 110 mg/dL.Your average blood pressure during screening is higher than 140/90 mmHg.I am willing to drink a special type of water for 8 weeks.
- Group 1: Control
- Group 2: Overfeeding
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age restriction for enrollment in this clinical trial greater than sixty years?
"To participate in this research study, the individual must be between 18 and 42 years old. There are 65 trials for minors and 303 for those older than 65."
How many participants is the study seeking to involve?
"Affirmative. The information found on clinicaltrials.gov supports that this research is currently recruiting individuals for participation. First announced on September 15th 2020, the study was most recently updated on January 27th 2022 and seeks to enrol 70 participants from a single medical centre."
Are there any open slots available for participation in this clinical trial?
"Affirmative. The clinicaltrials.gov website documents that this research is currently enrolling patients, with the initial post appearing on September 15th 2020 and last update occuring January 27th 2022 . This trial aims to recruit 70 people from a single medical center."
Am I a qualified participant of this research project?
"This research endeavour is recruiting 70 individuals with metabolic syndrome, aged 18 to 42. To be eligible for the study, participants must meet the following criteria: male or pre-menopausal female; body mass index between 25 and 30 kg/m2 (± 0.5 will be accepted); agreement to consume deuterium-labeled water (2H2O) over an 8 week period; willingness to remain physically active throughout their participation in this trial; consenting to random assignment into either a control group or receiving prescribed intervention ; and commitment towards full adherence of all procedures mandated by the clinical trial."
Share this study with friends
Copy Link
Messenger